MIME-Version: 1.0
Date: Mon, 3 Aug 2020 12:01:08 +0000
Message-ID: <CACNgykOUqqDvghLvCAWcriQZP8zdq873TPT_i9dfXutHr7Ag5Q@mail.gmail.com>
Subject: Takeda & Values
From: Josh Klein <josh@josh.is>
To: Chris at Indigo <chris@indigometrics.com>
Content-Type: multipart/alternative; boundary="000000000000ef929d05abf7e403"

--000000000000ef929d05abf7e403
Content-Type: text/plain; charset="UTF-8"

Well
<https://www.mckinsey.com/business-functions/strategy-and-corporate-finance/our-insights/how-asias-largest-pharma-is-leveraging-its-values-to-navigate-the-covid-19-crisis>
.

Also I note that they're a 50k person company, so perhaps worth bothering
with? ;)

- J

--000000000000ef929d05abf7e403
Content-Type: text/html; charset="UTF-8"
Content-Transfer-Encoding: quoted-printable

<div dir=3D"ltr"><div><a href=3D"https://www.mckinsey.com/business-function=
s/strategy-and-corporate-finance/our-insights/how-asias-largest-pharma-is-l=
everaging-its-values-to-navigate-the-covid-19-crisis">Well</a>.</div><div><=
br></div><div>Also I note that they&#39;re a 50k person company, so perhaps=
 worth bothering with? ;)<br></div><div><br></div><div>- J<br></div></div>

--000000000000ef929d05abf7e403--